Edition:
United States

Magellan Health Inc (MGLN.OQ)

MGLN.OQ on NASDAQ Stock Exchange Global Select Market

95.80USD
15 Dec 2017
Change (% chg)

$0.55 (+0.58%)
Prev Close
$95.25
Open
$95.05
Day's High
$96.50
Day's Low
$95.05
Volume
184,603
Avg. Vol
51,870
52-wk High
$99.20
52-wk Low
$64.05

Summary

Name Age Since Current Position

Barry Smith

64 2014 Executive Chairman of the Board, Chief Executive Officer

Mostafa Kamal

36 2015 Chief Executive Officer of Magellan Rx Management

Sanjeev Srivastava

49 2014 Chief Executive Officer - Magellan Healthcare

Caskie Lewis-Clapper

52 2004 Chief Human Resource Officer

Daniel Gregoire

61 2005 General Counsel, Secretary

William McBride

72 2004 Lead Independent Director

John Agwunobi

52 2014 Independent Director

Eran Broshy

58 2009 Independent Director

Michael Diament

48 2004 Independent Director

Perry Fine

64 2014 Independent Director

Kay James

67 2015 Independent Director

G. Scott MacKenzie

53 2016 Independent Director

Mary Sammons

70 2011 Independent Director

Joe Bogdan

2017 Senior Vice President, Corporate Finance

Biographies

Name Description

Barry Smith

Mr. Barry Michael Smith is Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Smith previously served as an operating partner for Health Evolution Partners, a private fund which invests in rapidly growing companies across the healthcare industry. He also previously served as chief executive officer and chairman of B&J Associates, Inc. and B&J Smith Investments, LLC, both of which are investment management companies. He founded and served as chairman, president and chief executive officer of VistaCare, Inc., a national provider of hospice services, from 1996 to 2002, and he served as chairman of VistaCare in 2003. Mr. Smith currently serves on the board of directors of The Ensign Group, Inc., a NASDAQ-listed diversified provider of healthcare services. Mr. Smith was last nominated for re-election as a director in 2016 due to his healthcare experience and expertise and favorable previous service as a director of the company from 2004 to 2008, and due to his appointment as the company's chief executive officer as of January 1, 2013.

Mostafa Kamal

Mr. Mostafa Kamal is Chief Executive Officer of Magellan Rx Management of the Company. Mr. Kamal previously served as senior vice president and general manager of Magellan Rx Management's specialty pharmacy business, as well as its chief underwriting officer. From 2011 to 2014, Mr. Kamal was vice president of pricing, underwriting and analytics. Before joining the company, he served as director of strategy and analytics at Medco Health Solutions, Inc. (now known as Express Scripts). He currently serves as a director of the Pharmaceutical Care Management Association.

Sanjeev Srivastava

Mr. Sanjeev K. Srivastava is Chief Executive Officer - Magellan Healthcare of the Company. He became chief executive officer of Magellan Plan Services in September 2013 and chief executive officer of Magellan Healthcare in February 2014. He previously served as president of the national and senior segments at CIGNA Health Care. Prior to joining CIGNA, he served in executive leadership positions with UnitedHealth Group and HealthNet.

Caskie Lewis-Clapper

Ms. Caskie Lewis-Clapper is Chief Human Resources Officer of the Company. Ms. Lewis-Clapper served as Human Resources Operations lead for Helix Health, a Baltimore, Maryland-based health care system. Prior to joining Helix, she was with General Physics Corporation, where as a staff consultant she worked with clients across several industries on learning, organizational development and performance improvement initiatives.

Daniel Gregoire

Mr. Daniel N. Gregoire is General Counsel and Secretary of the Company. Mr. Gregoire was executive vice president, general counsel and secretary of Oxford Health Plans, Inc., a New York Stock Exchange-listed managed care company, from 2000 to 2004. Prior to joining Oxford, Mr. Gregoire was an attorney and shareholder with Sheehan Phinney Bass & Green PA, a Manchester, New Hampshire-based law firm, from 1981 to 2000.

William McBride

Mr. William J. McBride is Lead Independent Director of the Company. Mr. McBride is currently retired. Prior to his retirement in 1995, Mr. McBride was a director of Value Health, Inc., a New York Stock Exchange-listed specialty managed-care company, which included Value Behavioral Health, one of the largest behavioral health managed care companies at the time. From 1987 to 1995, Mr. McBride served as president and chief operating officer of Value Health, Inc., overseeing all operational activities of the company and its subsidiaries. Prior to his tenure at Value Health, Mr. McBride spent 15 years in a variety of positions with INA Corporation and its successor, Cigna Corporation, including serving as president and chief executive officer of Cigna Healthplan, Inc. Mr. McBride currently serves on the board of directors of Women's Health USA, Inc., a privately-held healthcare services company, and Internet Healthcare Group, LLC, a venture capital group. He previously served on the board of Amerigroup Corporation, which was previously a publicly-traded health insurance company.

John Agwunobi

Dr. John O. Agwunobi, M.D., is Independent Director of the Company. He currently serves as chief health and nutrition officer of Herbalife Ltd., a New York Stock Exchange-traded global nutrition company. He previously served as the senior vice-president and president of Health and Wellness of Wal-Mart Stores, Inc. from September 2007 to April 2014, where he was responsible for all health related businesses of Wal-Mart in the U.S. and Puerto Rico. He previously served as the assistant secretary for health in the U.S. Department of Health and Human Services from 2005 to 2007 as part of the U.S. Public Health Service Commissioned Corps and as the secretary of health for the State of Florida from 2001 to 2005. Dr. Agwunobi is a board-certified pediatrician and holds Master of Public Health and Master of Business Administration degrees. He currently serves as the vice-chairman of the board of the U.S. African Development Foundation.

Eran Broshy

Mr. Eran Broshy is Independent Director of the Company. Mr. Broshy previously served for over a decade as the chief executive officer and chairman of the board of inVentiv Health, Inc., a privately-held (and until August 2010 a NASDAQ-listed) company that delivers a broad range of outsourced clinical and commercial services to bio-pharmaceutical companies. Prior to joining inVentiv, Mr. Broshy was a partner at The Boston Consulting Group ("BCG") and responsible for BCG's healthcare practice across the Americas. He currently serves on the board of directors of Theravance Biopharma, a NASDAQ-listed bio-pharmaceutical company, as chairman of ERT, a privately-held provider of data solutions to bio-pharmaceutical companies, and as chairman of DermaRite, a privately-held skin and wound care manufacturer. He is a member of the Corporation of the Massachusetts Institute of Technology.

Michael Diament

Mr. Michael S. Diament is Independent Director of the Company. He formerly served as portfolio manager and director of bankruptcies and restructurings from January 2001 to February 2006 for Q Investments, an investment management firm. He currently serves on the board of directors of Centrus Energy (formerly named USEC Inc.), a New York Stock Exchange-traded enriched uranium supply company, and through August 2016 served as chairman and on the board of directors of Dayco, LLC (formerly named Mark IV Industries, Inc.), a privately-held manufacturer of engine technology solutions.

Perry Fine

Dr. Perry G. Fine, M.D., is Independent Director of the Company. Dr. Fine is a professor in the Department of Anesthesiology of the School of Medicine at the University of Utah, where he serves on the faculty in the Pain Research Center, and is an attending physician in the Pain Management Center. He currently serves on the boards of directors of Ossipee Lake Alliance, a non-profit environmental organization, and Anne Stirba Cancer Foundation, a non-profit organization dedicated to fundraising for breast cancer research. He is past president of the American Academy of Pain Medicine. He was nominated for election for the first time as a director in 2014 due to his extensive experience in managed care and clinical issues as well as his experience serving on many boards of directors, including past service on the board of directors of a public company, VistaCare, Inc.

Kay James

Ms. Kay Coles James is Independent Director of the Company. Ms. James is the president and founder of the Gloucester Institute, a non-profit organization focused on developing future leaders. From June 2001 to January 2005, Ms. James served as director of the U.S. Office of Personnel Management, where she was principal human resources advisor to President George W. Bush. She has also served as secretary of Health and Human Resources for the Commonwealth of Virginia, where she was responsible for Medicare and Medicaid programs; a senior fellow at The Heritage Foundation; and assistant secretary of the U.S. Department of Health and Human Services. She currently serves on the board of trustees of The Heritage Foundation, on the board of directors of The PNC Financial Services Group, Inc., and on the board of directors of Cancer Treatment Centers of America.

G. Scott MacKenzie

Mr. G. Scott MacKenzie is Independent Director of the Company. He currently serves as the chief executive officer of M*Modal, Inc., a privately held clinical documentation service and technology company, a position which he has held since 2014. He previously served as the chief executive officer of Experian Health from 2013 to 2014 and as chief executive officer of Passport Health Communications from 2009 to 2014. Mr. MacKenzie serves on the board of directors of MedHost, Inc., a privately-held developer of healthcare financial software, and until March 2017 served on the board of directors of Invision Heart, Inc., a privately-held cardiac care solutions company. Mr. MacKenzie was nominated for election as a director due to his experience with healthcare technology and in the healthcare industry generally.

Mary Sammons

Ms. Mary F. Sammons is Independent Director of the Company. She is currently retired. She served as the chairman of the board of Rite Aid Corporation ("Rite Aid") from 2008 until 2012 and served on the board of directors of Rite Aid from 1999 to June 2013. From 2003 until 2010 Ms. Sammons served as chief executive officer of Rite Aid. Ms. Sammons is a member of the board of directors and lead director of StanCorp Financial Group, Inc., a New York Stock Exchange-listed insurance and financial services company, until March 7, 2016, when it was acquired by Meiji Yasuda, a Japanese insurance and financial institution.

Joe Bogdan

Basic Compensation

Name Fiscal Year Total

Barry Smith

7,451,380

Mostafa Kamal

1,771,800

Sanjeev Srivastava

2,656,890

Caskie Lewis-Clapper

1,147,530

Daniel Gregoire

1,488,070

William McBride

270,001

John Agwunobi

245,001

Eran Broshy

267,501

Michael Diament

275,001

Perry Fine

240,001

Kay James

240,001

G. Scott MacKenzie

120,611

Mary Sammons

260,001

Joe Bogdan

--
As Of  30 Dec 2016